SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-021274
Filing Date
2010-04-22
Accepted
2010-04-22 16:18:41
Documents
4
Period of Report
2010-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-8558_18k.htm 8-K 53233
2 EX-3.1 a10-8558_1ex3d1.htm EX-3.1 8803
3 EX-10.1 a10-8558_1ex10d1.htm EX-10.1 100939
4 EX-10.2 a10-8558_1ex10d2.htm EX-10.2 24396
  Complete submission text file 0001104659-10-021274.txt   189264
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 10764708
SIC: 2834 Pharmaceutical Preparations